<?xml version='1.0' encoding='UTF-8'?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-06-24T05:48:21Z</responseDate>
  <request verb="GetRecord" identifier="oai:meral.edu.mm:recid/3149" metadataPrefix="oai_dc">https://meral.edu.mm/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:meral.edu.mm:recid/3149</identifier>
        <datestamp>2021-12-13T01:12:08Z</datestamp>
        <setSpec>1582963366982:1596631680078</setSpec>
        <setSpec>user-um1</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns="http://www.w3.org/2001/XMLSchema" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Detection of Schistosoma Antibodies and exploration of associated factors among local residents around Inlay Lake, Southern Shan State, Myanmar</dc:title>
          <dc:creator>Htin Zaw Soe</dc:creator>
          <dc:creator>Cho Cho Oo</dc:creator>
          <dc:creator>Tin Ohn Myat</dc:creator>
          <dc:creator>Nay Soe Maung</dc:creator>
          <dc:description>&lt;p&gt;Abstract&lt;br&gt;
Background: Schistosomiasis is a chronic parasitic disease caused by blood flukes (trematode worms) of the genus&lt;br&gt;
Schistosoma. Its transmission has been reported in 78 countries affecting at least 258 million people world-wide. It&lt;br&gt;
was documented that S. japonicum species was prevalent in Shan State, Myanmar, but the serological study was&lt;br&gt;
not conducted yet. General objective of the present study was to detect schistosoma antibodies and explore&lt;br&gt;
associated factors among local residents living around Inlay Lake, Nyaung Shwe Township, and Southern Shan&lt;br&gt;
State, Myanmar.&lt;br&gt;
Methods: An exploratory and cross-sectional analytic study was conducted among local residents (n = 315) in&lt;br&gt;
selected rural health center (RHC) areas from December 2012 through June 2013. The participants were interviewed&lt;br&gt;
with pretested semi-structured questionnaires and their blood samples (serum) were tested using Schistosomiasis&lt;br&gt;
Serology Microwell ELISA test kits (sensitivity 100% and specificity 85%) which detected IgG antibodies but could&lt;br&gt;
not distinguish between a new and past infection. Data collected were analysed by SPSS software 16.0 and&lt;br&gt;
associations of variables were determined by Chi-squared test with a significant level set at 0.05.&lt;br&gt;
Results: Schistosoma seroprevalence (IgG) in study area was found to be 23.8% (95% CI: 18.8&amp;ndash;28.8%). The present&lt;br&gt;
study is the first and foremost study producing serological evidence of schistosoma infection&amp;mdash;one of the&lt;br&gt;
neglected tropical diseases&amp;mdash;in local people of Myanmar. The factors significantly associated with seropositivity&lt;br&gt;
were being male [OR = 2.6 (95% CI: 1.5&amp;ndash;4.49), P &amp;lt; 0.001], residence [OR = 3.41 (95% CI: 1.6-7.3), P &amp;lt; 0.05 for Khaung&lt;br&gt;
Daing vs. Min Chaung] and education levels [OR = 4.5 (95% CI: 1.18&amp;ndash;17.16),&lt;br&gt;
P &amp;lt; 0.05 for illiterate/3Rs level vs. high/graduate and OR = 3.16 (95% CI: 1.26&amp;ndash;7.93),&lt;br&gt;
P &amp;lt; 0.05 for primary/middle level vs. high/graduate] all factors classically associated with risk of schistosoma&lt;br&gt;
infection. None of the behavioural factors tested were significantly associated with seropositivity.&lt;br&gt;
Conclusion: Schistosoma infection serologically detected was most probably present at some time in this location&lt;br&gt;
of Myanmar, and this should be further confirmed parasitologically and kept under surveillance. Proper trainings on&lt;br&gt;
diagnosis, treatment, prevention and control of schistosomiasis should be provided to the healthcare providers.&lt;br&gt;
Trial registration: ISRCTN ISRCTN73824458. Registered 28 September 2014, retrospectively registered.&lt;/p&gt;</dc:description>
          <dc:date>2017-09-19</dc:date>
          <dc:identifier>http://hdl.handle.net/20.500.12678/0000003149</dc:identifier>
          <dc:identifier>https://meral.edu.mm/records/3149</dc:identifier>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
